Labor hour award center for biologics evaluation and research (cber) - regulatory review staff training program on advanced manufacturing for regenerative medicine therapy support services FDA…

Ended Awarded Last action

Contract number
75F40121F19052
Awardee
Awarding agency
Obligated
$705,164

Award facts

Contract value 100% obligated
$705,163.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Rockville, MD 20857, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00004 -$7,370
Exercise an Option P00003 $362,110
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $350,424

About this award

This is a labor hour award from the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. for a Regulatory Review Staff Training Program on Advanced Manufacturing for Regenerative Medicine Therapy Support Services. The contract has a ceiling value of $705,163.79 and a completion date of September 26, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the Mission Oriented Business Integrated Services (MOBIS) GSA Schedule. The contract does not have a set-aside designation. Booz Allen Hamilton Inc. is the prime contractor on this award, which falls under the parent company Booz Allen Hamilton Holding Corporation. The award supports regulatory review staff training on advanced manufacturing for regenerative medicine therapies, indicating the FDA's efforts to build expertise in this emerging field.

Description

Labor hour award center for biologics evaluation and research (cber) - regulatory review staff training program on advanced manufacturing for regenerative medicine therapy support services FDA three-way-matching invoice clause-COR: michele.wiggins

Quick answers

Who was awarded contract 75F40121F19052?

75F40121F19052 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on September 17, 2021.

How much is contract 75F40121F19052 worth?

The government has obligated $705,164 on 75F40121F19052.

Is contract 75F40121F19052 an order under another contract?

Yes. 75F40121F19052 is a BPA call under GS23F9755H-HHSF223201510027B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).

Was contract 75F40121F19052 competed?

The extent of competition for 75F40121F19052 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award